Publications by authors named "James Economou"

Claim this Profile
R
Roadmap for Research and Scholarship in General Surgery Residency Training: Report of the Research Subcommittee of Blue Ribbon Committee II on Surgical Education and Training.
Mary T Hawn, Jeff B Matthews, Ginny L Bumgardner, James Economou, Kamal Itani

Ann Surg· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One of the Most Important Phone Calls of My Career.
James S Economou

Ann Surg· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin 32 expression in human melanoma.
Helicia Paz, Jennifer Tsoi, Anusha Kalbasi, Catherine S Grasso, William H McBride, James S Economou

J Transl Med· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy Resistance by Inflammation-Induced Dedifferentiation.
Arnav Mehta, Yeon Joo Kim, Lidia Robert, Jennifer Tsoi, Begoña Comin-Anduix, James S Economou

Cancer Discov· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Postinfusion Phenotypic Differences in Fresh Versus Cryopreserved TCR Engineered Adoptive Cell Therapy Products.
Theodore S Nowicki, Helena Escuin-Ordinas, Earl Avramis, Bartosz Chmielowski, Thinle Chodon, James S Economou

J Immunother· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Research in the 21st Century.
James S Economou, Dennis J Slamon, Antoni Ribas, Michael E Phelps

Ann Surg· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engines of Discovery and Innovation.
James Steven Economou

Ann Surg· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender bias in biomedical research.
James S Economou

Surgery· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adoptive transfer of MART-1 T-cell receptor transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanoma.
Thinle Chodon, Begoña Comin-Anduix, Bartosz Chmielowski, Richard C Koya, Zhongqi Wu, James S Economou

Clin Cancer Res· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histone deacetylase inhibitor sensitizes apoptosis-resistant melanomas to cytotoxic human T lymphocytes through regulation of TRAIL/DR5 pathway.
Ali R Jazirehi, Siavash K Kurdistani, James S Economou

J Immunol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpha fetoprotein DNA prime and adenovirus boost immunization of two hepatocellular cancer patients.
Lisa H Butterfield, James S Economou, T Clark Gamblin, David A Geller

J Transl Med· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aberrant apoptotic machinery confers melanoma dual resistance to BRAF(V600E) inhibitor and immune effector cells: immunosensitization by a histone deacetylase inhibitor.
Ali R Jazirehi, Ramin Nazarian, Antoni Xavier Torres-Collado, James S Economou

Am J Clin Exp Immunol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allelic exclusion and peripheral reconstitution by TCR transgenic T cells arising from transduced human hematopoietic stem/progenitor cells.
Francesca Giannoni, Cinnamon L Hardee, Jennifer Wherley, Eric Gschweng, Shantha Senadheera, James S Economou

Mol Ther· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multifunctional T-cell analyses to study response and progression in adoptive cell transfer immunotherapy.
Chao Ma, Ann F Cheung, Thinle Chodon, Richard C Koya, Zhongqi Wu, James S Economou

Cancer Discov· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A society in transition: presidential remarks at the 65th Annual SSO Cancer Symposium.
James S Economou

Ann Surg Oncol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteasome inhibition blocks NF-κB and ERK1/2 pathways, restores antigen expression, and sensitizes resistant human melanoma to TCR-engineered CTLs.
Ali R Jazirehi, James S Economou

Mol Cancer Ther· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cell receptor (TCR)-transgenic CD8 lymphocytes rendered insensitive to transforming growth factor beta (TGFβ) signaling mediate superior tumor regression in an animal model of adoptive cell therapy.
Jon G Quatromoni, Yue Wang, Dan D Vo, Lilah F Morris, Ali R Jazirehi, James S Economou

J Transl Med· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulation by imiquimod in patients with high-risk primary melanoma.
Rupa Narayan, Hong Nguyen, Jason J Bentow, Lauren Moy, Diana K Lee, James S Economou

J Invest Dermatol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation enhances regulatory T cell representation.
Evelyn L Kachikwu, Keisuke S Iwamoto, Yu-Pei Liao, John J DeMarco, Nzhde Agazaryan, James S Economou

Int J Radiat Oncol Biol Phys· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cell receptor transgenic lymphocytes infiltrating murine tumors are not induced to express foxp3.
Jon G Quatromoni, Lilah F Morris, Timothy R Donahue, Yue Wang, William McBride, James S Economou

J Hematol Oncol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CTLA4 blockade induces frequent tumor infiltration by activated lymphocytes regardless of clinical responses in humans.
Rong Rong Huang, Jason Jalil, James S Economou, Bartosz Chmielowski, Richard C Koya

Clin Cancer Res· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular mechanism of MART-1+/A*0201+ human melanoma resistance to specific CTL-killing despite functional tumor-CTL interaction.
Ali R Jazirehi, Stavroula Baritaki, Richard C Koya, Benjamin Bonavida, James S Economou

Cancer Res· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitro.
Swagatam Ray, Arvind Chhabra, Nitya G Chakraborty, Upendra Hegde, David I Dorsky, James S Economou

Clin Immunol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming barriers to programming a therapeutic cellular immune response to fight melanoma.
David Baltimore, Owen N Witte, Lili Yang, James Economou, Antoni Ribas

Pigment Cell Melanoma Res· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obstacles to and opportunities for more effective peptide-based therapeutic immunization in human melanoma.
Swagatam Ray, Arvind Chhabra, Shikhar Mehrotra, Nitya G Chakraborty, Antoni Ribas, James Economou

Clin Dermatol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis